Epizyme reported $57.33M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Amarin AMRN:US 157.27M 34.34M
Amgen AMGN:US $ 4.42B 680M
Avrobio Inc AVRO:US 27.77M 1.64M
Biogen BIIB:US $ 2648.2M 727.1M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Cerulean Pharma CERU:US $ 8.4M 1.14M
Daiichi Sankyo 4568:JP 245.94B 38.74B
Eisai 4523:JP Y 176828M 34876M
Epizyme EPZM:US $ 57.33M 2.29M
Exelixis EXEL:US $ 335.72M 62.98M
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Glaxosmithkline GSK:US 5.85B 1.13B
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Macrogenics MGNX:US $ 67.82M 9.92M
Merk MRK:US $ 9666M 666M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Novartis NVS:US 10.86B 895M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Spectrum Pharmaceuticals SPPI:US $ 25.39M 11.33M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Xencor XNCR:US $ 58.18M 854K